Studies of genital wart (GW) incidence
Study | Country, year | Interval for defining recurrence (months) | Age and sex | Episode type | Annual incidence/100 000 population (95% CI)* |
Present† | England, 2008–2009 | 2 (base case) | All | New | 157 |
Recurrent | 133 | ||||
Sensitivity analyses | 3 | All | Recurrent | 116 | |
4 | All | Recurrent | 105 | ||
6 | All | Recurrent | 91 | ||
Cassell et al19 | UK, 1998–2000 | Not reported | All | All | 307.6 (305.5 to 309.8) males |
236.2 (234.2 to 238.4) females | |||||
Other studies of GW incidence | |||||
Castellsagué et al20 | Spain, 2005 | Not reported | 14–64 years | New | 117.86 |
Recurrent | 42.57 | ||||
Resistant | 21.72 | ||||
Hillemanns et al21 | Germany, 2005 | Not reported | 14–65-year-old females | New | 114 (109 to 119) |
Recurrent | 35 (32 to 37) | ||||
Lukasiewicz et al22 | France, 2000 | Not reported | All | All | 107 |
Pirotta et al23 | Australia, 2000–2006 | Not reported | All | All | 219 (188 to 249)‡ |
Marra et al24 | Canada, 2006 | 12 | >15 years | All | 126‡ |
Hoy et al25 | USA, 2004 | 12 | All | All | 120‡ |
Insigna et al26 | USA, 2000 | 12 | All | All | 165 (males) ‡ |
167 (females) |
* 95% CI are not presented for studies that did not report them.
† 95% CIs calculated for the rates are not reported because they were too narrow to be a meaningful representation of uncertainty.
‡ Adapted from reported figures per 1000 population or person-years. Methods suggest denominator equivalent to population.